Australia’s Neuren Pharma surges over 10% on US patent win for rare disease drug
Australia's Neuren Pharma surges over 10% on US patent win for rare disease drugSource: Investing.com
Australia's Neuren Pharma surges over 10% on US patent win for rare disease drugSource: Investing.com
Microsoft, OpenAI clash over AGI clause in $10 bln deal – The InformationSource: Investing.com
Mars-Kellanova takeover not anticompetitive, FTC saysSource: Investing.com
Wall St futures flat amid Israel-Iran truce, Powell rate cautionSource: Investing.com
After-hours movers: Micron Technology, Steelcase and moreSource: Investing.com
Boeing taps Northrop exec to lead Air Force One program - Breaking DefenseSource: Investing.com
Mercedes-Benz unveils electric hypercar with new techSource: Investing.com
Tariff shock looms, but AI rally likely to roll on as Fed cuts near: JPMSource: Investing.com
Google's DeepMind launches AlphaGenome AI tool for DNA analysisSource: Investing.com
Shell considers acquiring BP in potential mega oil deal - WSJSource: Investing.com